Ironwood Pharmaceuticals is trading at $4.13 (-5.30%) as biotechnology stocks retreat broadly.
- The sector is down 2.47%, while the Nasdaq Composite is down 0.85%, reflecting risk-off positioning and profit-taking after the prior biotech rally.
- No company-specific announcement dated August 20, 2026, was identified; the latest major company update was August 6’s raised 2026 guidance.